Cargando…
Allergen Immunotherapy: Biomarkers and Clinical Outcome Measures
Clinical trials for allergen immunotherapy products’ development and approval are conducted, aiming to monitor safety and efficacy of them. Symptom scores and the use of rescue medication are the primary clinical endpoints used in the conducted clinical trials, while Quality of Life scores and sympt...
Autor principal: | Pitsios, Constantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901403/ https://www.ncbi.nlm.nih.gov/pubmed/33633455 http://dx.doi.org/10.2147/JAA.S267522 |
Ejemplares similares
-
Allergen Immunotherapy: New Insights into an Old Treatment
por: Pitsios, Constantinos
Publicado: (2022) -
Workup and Clinical Assessment for Allergen Immunotherapy Candidates
por: Pitsios, Constantinos, et al.
Publicado: (2022) -
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
por: Sahiner, Umit M., et al.
Publicado: (2023) -
Mechanisms and biomarkers of successful allergen-specific immunotherapy
por: López, Juan-Felipe, et al.
Publicado: (2022) -
Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020)